BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
MFC
Manulife Financial Corporation
There isn't enough reported data to score MFC yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
MFC Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| N/A | |
| N/A |
MFC's profitability is currently healthy, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like MFC.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | โ |
| Current | 12x | $50.51 | โ |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over MFC in the historical PE scenario, which offers more potential upside but is not a forecast.
MFC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.9x | $17.83 | -59% |
| Fair | 9x | $23.36 | -47% |
| Expensive | 16x | $41.54 | -5.4% |
| Current | 17x | $43.92 | โ |
Historical ranges are pointers, not guarantees.
MFC's PE is 17x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
MFC Forward outlook
There aren't enough analyst estimates for MFC to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over MFC on earnings, with stronger typical year-over-year growth.
MFC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $2.59 | +19% |
| Q1 2026 | $2.43 | +31% |
| Q4 2025 | $2.16 | +8.5% |
| Q3 2025 | $2.19 | +10% |
| Q2 2025 | $2.17 | +32% |
| Q1 2025 | $1.85 | +13% |
| Q4 2024 | $1.99 | +8.7% |
| Q3 2024 | $1.99 | +4.7% |
MFC's earnings per share have climbed steadily: $2.59 over the past year, up 19% from the year before, and higher year over year for eight quarters in a row.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over MFC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over MFC on profitability, with a higher operating margin.
MFC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $13.9B | -52% |
| Q1 2026 | $8.7B | +36% |
| Q4 2025 | $6B | +104% |
| Q3 2025 | $12.2B | +19% |
| Q2 2025 | $28.9B | +123% |
| Q1 2025 | $6.4B | -74% |
| Q3 2024 | $10.2B | -27% |
| Q2 2024 | $13B | -20% |
MFC's revenue has slid since its 2025 peak: $13.9B last quarter, down 52% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +8.6 points |
| Q1 2026 | 12% | +4.2 points |
| Q4 2025 | 22% | -28 points |
| Q3 2025 | 13% | -3.2 points |
| Q2 2025 | 5.5% | -2 points |
| Q1 2025 | 7.7% | +4.2 points |
| Q4 2024 | 50% | N/A |
| Q3 2024 | 16% | +10 points |
MFC's operating margin was 14% last quarter, up 8.6 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
MFC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.4B | +25% |
| Q1 2026 | $2.5B | -47% |
| Q4 2025 | $6B | +21% |
| Q3 2025 | $6.7B | +27% |
| Q2 2025 | $5.1B | 0% |
| Q1 2025 | $4.7B | +46% |
| Q4 2024 | $5B | +16% |
| Q3 2024 | $5.3B | +37% |
MFC has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
MFC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -1.7x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -1.7x | Net Cash |
| Q4 2024 | -1.6x | Net Cash |
| Q3 2024 | -1.4x | Net Cash |
MFC has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
MFC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.1 | Neutral |
| Stochastic | 56.6 | Neutral |
MFC's weekly RSI is 58 (neutral) and its Stochastic is 57 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over MFC on valuation relative to its sector.
MFC PE vs Financial Services Sector
| Metric | MFC | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 13x | 30% above |
| PE % | 94 | 63 | 31 pts above |
MFC is trading at 17x earnings, a 30% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
MFC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $43.7 | 0.5% above |
| 20 week MA | $43.5 | 1% above |
| 50 week MA | $39.7 | 11% above |
| 100 week MA | $35.4 | 24% above |
| 200 week MA | $29.1 | 51% above |
MFC has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
MFC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.1 | $17.5 | -13% |
| 2021 | $17.5 | $18.7 | +6.8% |
| 2022 | $18.7 | $17.9 | -4.4% |
| 2023 | $17.9 | $22.1 | +24% |
| 2024 | $22.1 | $30.7 | +39% |
| 2025 | $30.7 | $36.6 | +19% |
| 2026 YTD | $36.6 | $43.9 | +20% |
MFC has the edge over BAC on returns for 2026, with the stronger performance.